Condensed Balance Sheets - USD ($)		Sep. 30, 2021	Feb. 10, 2021
Current assets:
Cash		$ 839,000	$ 0
Total current assets		839,000	0
Deferred offering costs		493,000	20,000
Total assets		1,332,000	20,000
Current liabilities
Due to investors		836,000
Accounts payable, including approximately $70,000 of offering costs		87,000	0
Accrued offering costs		275,000	0
Sponsor loan		200,000	0
Total liabilities		1,398,000	0
Commitments and Contingencies (see Note 7)
SHAREHOLDER'S EQUITY (DEFICIT)
Preferred shares, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding		0	0
Additional paid-in-capital		24,000	24,000
Accumulated deficit		(91,000)	(5,000)
Total shareholder's equity (deficit)		(66,000)	20,000
Total liabilities and shareholder's equity (deficit)		1,332,000	20,000
Common Class A [Member]
SHAREHOLDER'S EQUITY (DEFICIT)
Common Stock, Value		0	0
Common Class B [Member]
SHAREHOLDER'S EQUITY (DEFICIT)
Common Stock, Value	[1],[2]	$ 1,000	$ 1,000

[1] Includes an aggregate of 656,250 Class B ordinary shares held by the Sponsor that are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full.

[2] Share amounts have been retroactively restated to reflect the surrender of 2,156,250 Class B ordinary shares by our Sponsor on June 30, 2021 which reduced Class B ordinary shares outstanding (see Note 4) and the share recapitalization on October 21, 2021 which increased Class B ordinary shares outstanding to 5,031,250 shares.